Option exercise and 10b5-1 sales reported by CAPR (NASDAQ: CAPR)

Rhea-AI Filing Summary

CAPR proposed sale notice: The filing lists 7,529 shares of Common Stock to be sold on 04/02/2026 in connection with an exercise of stock options for cash. It also reports recent 10b5-1 sales by Karimah Es Sabar of 53,735 and 61,265 shares on 04/01/2026 and 03/31/2026, respectively, with proceeds shown.

Insights

Insider Transactions Analyst

Routine insider notice showing option exercise plus prior 10b5-1 sales.

The filing records an exercise-based sale of 7,529 shares to the issuer for cash and documents two recent planned 10b5-1 dispositions by Karimah Es Sabar totaling 114,...

These items are administrative disclosures of insider liquidity; cash flows are to/from the reporting parties as shown. Subsequent filings would show settlement details and updated holdings.

Key Figures

Shares to be sold (exercise): 7,529 shares 10b5-1 sale (04/01/2026): 53,735 shares 10b5-1 sale (03/31/2026): 61,265 shares

3 metrics

Shares to be sold (exercise) 7,529 shares Exercise of stock options on 04/02/2026

10b5-1 sale (04/01/2026) 53,735 shares Proceeds $1,667,225.10

10b5-1 sale (03/31/2026) 61,265 shares Proceeds $1,848,242.52

Key Terms

10b5-1, Form 144, Exercise of Stock Options

3 terms

10b5-1 regulatory

"10b5-1 Sales for KARIMAH ES SABAR 04/01/2026"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Options financial

"Securities To Be Sold | Exercise of Stock Options | Issuer"

FAQ

What does CAPR's Form 144 say about shares to be sold?

The filing lists 7,529 shares of Common Stock to be sold on 04/02/2026 tied to an exercise of stock options for cash. It identifies the method as an exercise to the issuer rather than an open-market block sale.

Who conducted recent 10b5-1 sales reported in the CAPR filing?

The filing shows two 10b5-1 sales by Karimah Es Sabar: 53,735 shares on 04/01/2026 and 61,265 shares on 03/31/2026. Reported proceeds for each sale are included in the notice.

How much cash was reported from the recent 10b5-1 sales?

The filing shows proceeds of $1,667,225.10 for the 53,735-share sale (04/01/2026) and $1,848,242.52 for the 61,265-share sale (03/31/2026). These figures are listed alongside each sale entry.

Is the 04/02/2026 transaction an open-market sale or option exercise?

The entry for 04/02/2026 is labeled an Exercise of Stock Options with the issuer receiving cash for 7,529 shares. The filing treats this as an option exercise transaction rather than a standard market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001873796
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAPRICOR THERAPEUTICS INC
SEC File Number	001-34058
Address of Issuer	10865 Road to the Cure, Suite 150 San Diego CALIFORNIA 92121
Phone	8587271755
Name of Person for Whose Account the Securities are To Be Sold	Karimah Es Sabar
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7529	226773.48	57510635	04/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/02/2026	Exercise of Stock Options	Issuer			7529	04/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for KARIMAH ES SABAR 10865 Road to the Cure, Suite 150 San Diego CA 92121	Common	04/01/2026	53735	1667225.10
10b5-1 Sales for KARIMAH ES SABAR 10865 Road to the Cure, Suite 150 San Diego CA 92121	Common	03/31/2026	61265	1848242.52

144: Remarks and Signature

Remarks
Date of Notice	04/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/27/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Karimah Es Sabar
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)